Literature DB >> 23406900

Smad4-Irf6 genetic interaction and TGFβ-mediated IRF6 signaling cascade are crucial for palatal fusion in mice.

Jun-ichi Iwata1, Akiko Suzuki, Richard C Pelikan, Thach-Vu Ho, Pedro A Sanchez-Lara, Mark Urata, Michael J Dixon, Yang Chai.   

Abstract

Cleft palate is one of the most common human birth defects and is associated with multiple genetic and environmental risk factors. Although mutations in the genes encoding transforming growth factor beta (TGFβ) signaling molecules and interferon regulatory factor 6 (Irf6) have been identified as genetic risk factors for cleft palate, little is known about the relationship between TGFβ signaling and IRF6 activity during palate formation. Here, we show that TGFβ signaling regulates expression of Irf6 and the fate of the medial edge epithelium (MEE) during palatal fusion in mice. Haploinsufficiency of Irf6 in mice with basal epithelial-specific deletion of the TGFβ signaling mediator Smad4 (Smad4(fl/fl);K14-Cre;Irf6(+/R84C)) results in compromised p21 expression and MEE persistence, similar to observations in Tgfbr2(fl/fl);K14-Cre mice, although the secondary palate of Irf6(+/R84C) and Smad4(fl/fl);K14-Cre mice form normally. Furthermore, Smad4(fl/fl);K14-Cre;Irf6(+/R84C) mice show extra digits that are consistent with abnormal toe and nail phenotypes in individuals with Van der Woude and popliteal pterygium syndromes, suggesting that the TGFβ/SMAD4/IRF6 signaling cascade might be a well-conserved mechanism in regulating multiple organogenesis. Strikingly, overexpression of Irf6 rescued p21 expression and MEE degeneration in Tgfbr2(fl/fl);K14-Cre mice. Thus, IRF6 and SMAD4 synergistically regulate the fate of the MEE, and TGFβ-mediated Irf6 activity is responsible for MEE degeneration during palatal fusion in mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406900      PMCID: PMC3585659          DOI: 10.1242/dev.089615

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  55 in total

1.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

Review 2.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.

Authors:  B L Black; E N Olson
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

3.  TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway.

Authors:  B A Hocevar; T L Brown; P H Howe
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

4.  The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.

Authors:  Matthew D Westfall; Deborah J Mays; Joseph C Sniezek; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects.

Authors:  Yoshihiro Ito; Jae Yong Yeo; Anna Chytil; Jun Han; Pablo Bringas; Akira Nakajima; Charles F Shuler; Harold L Moses; Yang Chai
Journal:  Development       Date:  2003-11       Impact factor: 6.868

Review 6.  An update on the aetiology of orofacial clefts.

Authors:  F K Wong; U Hagg
Journal:  Hong Kong Med J       Date:  2004-10       Impact factor: 2.227

7.  Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.

Authors:  R H Chen; Y H Su; R L Chuang; T Y Chang
Journal:  Oncogene       Date:  1998-10-15       Impact factor: 9.867

8.  Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes.

Authors:  Shinji Kondo; Brian C Schutte; Rebecca J Richardson; Bryan C Bjork; Alexandra S Knight; Yoriko Watanabe; Emma Howard; Renata L L Ferreira de Lima; Sandra Daack-Hirsch; Achim Sander; Donna M McDonald-McGinn; Elaine H Zackai; Edward J Lammer; Arthur S Aylsworth; Holly H Ardinger; Andrew C Lidral; Barbara R Pober; Lina Moreno; Mauricio Arcos-Burgos; Consuelo Valencia; Claude Houdayer; Michel Bahuau; Danilo Moretti-Ferreira; Antonio Richieri-Costa; Michael J Dixon; Jeffrey C Murray
Journal:  Nat Genet       Date:  2002-09-03       Impact factor: 38.330

9.  Human Smad3 and Smad4 are sequence-specific transcription activators.

Authors:  L Zawel; J L Dai; P Buckhaults; S Zhou; K W Kinzler; B Vogelstein; S E Kern
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

10.  Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis.

Authors:  Rodrigo Cuervo; Luis Covarrubias
Journal:  Development       Date:  2003-11-26       Impact factor: 6.868

View more
  40 in total

Review 1.  Genetics and signaling mechanisms of orofacial clefts.

Authors:  Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-07-15       Impact factor: 2.344

Review 2.  TGF-β Family Signaling in Epithelial Differentiation and Epithelial-Mesenchymal Transition.

Authors:  Kaoru Kahata; Mahsa Shahidi Dadras; Aristidis Moustakas
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

3.  An Nfic-hedgehog signaling cascade regulates tooth root development.

Authors:  Yang Liu; Jifan Feng; Jingyuan Li; Hu Zhao; Thach-Vu Ho; Yang Chai
Journal:  Development       Date:  2015-08-20       Impact factor: 6.868

4.  Analysis of human soft palate morphogenesis supports regional regulation of palatal fusion.

Authors:  Adrian Danescu; Melanie Mattson; Carly Dool; Virginia M Diewert; Joy M Richman
Journal:  J Anat       Date:  2015-08-24       Impact factor: 2.610

5.  Homozygous stop-gain variant in LRRC32, encoding a TGFβ receptor, associated with cleft palate, proliferative retinopathy, and developmental delay.

Authors:  Tamar Harel; Ephrat Levy-Lahad; Muhannad Daana; Hadas Mechoulam; Smadar Horowitz-Cederboim; Michal Gur; Vardiella Meiner; Orly Elpeleg
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

6.  Genetic factors define CPO and CLO subtypes of nonsyndromicorofacial cleft.

Authors:  Lulin Huang; Zhonglin Jia; Yi Shi; Qin Du; Jiayu Shi; Ziyan Wang; Yandong Mou; Qingwei Wang; Bihe Zhang; Qing Wang; Shi Ma; He Lin; Shijun Duan; Bin Yin; Yansong Lin; Yiru Wang; Dan Jiang; Fang Hao; Lin Zhang; Haixin Wang; Suyuan Jiang; Huijuan Xu; Chengwei Yang; Chenghao Li; Jingtao Li; Bing Shi; Zhenglin Yang
Journal:  PLoS Genet       Date:  2019-10-14       Impact factor: 5.917

7.  Identification of Smad-dependent and -independent signaling with transforming growth factor-β type 1/2 receptor inhibition in palatogenesis.

Authors:  Yoshimi Suzuki; Akira Nakajima; Takayuki Kawato; Koichi Iwata; Mitsuru Motoyoshi; Charles F Shuler
Journal:  J Oral Biol Craniofac Res       Date:  2020-01-16

8.  A pilot study: Screening target miRNAs in tissue of nonsyndromic cleft lip with or without cleft palate.

Authors:  Shan Wang; Changsheng Sun; Yan Meng; Bing Zhang; Xin Wang; Yanguo Su; Lei Shi; Eryang Zhao
Journal:  Exp Ther Med       Date:  2017-03-21       Impact factor: 2.447

9.  WNT/β-Catenin Signaling Regulates Multiple Steps of Myogenesis by Regulating Step-Specific Targets.

Authors:  Akiko Suzuki; Richard C Pelikan; Junichi Iwata
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

Review 10.  Toward an orofacial gene regulatory network.

Authors:  Youssef A Kousa; Brian C Schutte
Journal:  Dev Dyn       Date:  2015-09-17       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.